when should i stop taking glp 1 Your guide to GLP-1 side effects Can you keep the weight

Abstract Despite Polycystic Ovary Syndrome (PCOS) is a very prevalent disorder among women of reproductive age, there is widespread agreement that until now, no pharmacological options are available to tackle the entire spectrum of clinical manifestations encountered in the clinical practice

Published May 28, 2025

J., Coskun, T., Thomas, M

One facility had received multiple warning letters from the U.S

CareFirst BlueCross BlueShield coverage criteria Wegovy is FDA-approved for chronic weight management (BMI 30+, or 27+ with a weight-related comorbidity) and for cardiovascular risk reduction in adults with established CVD it is a weight-loss and CV drug, not a diabetes drug